Polydex Pharmaceuticals Price Prediction
| POLXFDelisted Stock | USD 1.96 0.01 0.51% |
Oversold Vs Overbought
63
Oversold | Overbought |
Using Polydex Pharmaceuticals hype-based prediction, you can estimate the value of Polydex Pharmaceuticals from the perspective of Polydex Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Polydex Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Polydex because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Polydex Pharmaceuticals after-hype prediction price | USD 1.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Polydex |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Polydex Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Polydex Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Polydex Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Polydex Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Polydex Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Polydex Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Polydex Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Polydex Pharmaceuticals' historical news coverage. Polydex Pharmaceuticals' after-hype downside and upside margins for the prediction period are 1.96 and 1.96, respectively. We have considered Polydex Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Polydex Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Polydex Pharmaceuticals is based on 3 months time horizon.
Polydex Pharmaceuticals Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Polydex Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Polydex Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Polydex Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.96 | 1.96 | 0.00 |
|
Polydex Pharmaceuticals Hype Timeline
Polydex Pharmaceuticals is at this time traded for 1.96. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Polydex is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Polydex Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 1.96. The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Polydex Pharmaceuticals recorded a loss per share of 0.13. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 23rd of June 1997. Assuming the 90 days horizon the next anticipated press release will be within a week. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.Polydex Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Polydex Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Polydex Pharmaceuticals' future price movements. Getting to know how Polydex Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Polydex Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PHLI | PacificHealth Laboratories | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ICCC | ImmuCell | (0.08) | 5 per month | 2.33 | (0.03) | 3.40 | (3.29) | 21.64 | |
| SNT | Senstar Technologies | 0.01 | 4 per month | 1.15 | 0.17 | 10.04 | (2.50) | 35.03 | |
| NAII | Natural Alternatives International | 0.03 | 6 per month | 0.00 | (0.07) | 7.14 | (6.10) | 30.71 | |
| PGNT | Paragon Technologies | 0.00 | 0 per month | 2.29 | 0.01 | 8.72 | (5.00) | 17.95 |
Polydex Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Polydex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Polydex using various technical indicators. When you analyze Polydex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Polydex Pharmaceuticals Predictive Indicators
The successful prediction of Polydex Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Polydex Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Polydex Pharmaceuticals based on analysis of Polydex Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Polydex Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Polydex Pharmaceuticals's related companies.
Story Coverage note for Polydex Pharmaceuticals
The number of cover stories for Polydex Pharmaceuticals depends on current market conditions and Polydex Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Polydex Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Polydex Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Polydex Pink Sheet
If you are still planning to invest in Polydex Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polydex Pharmaceuticals' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |